vs
Ametek（AME）与TECOGEN INC.（TGEN）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是TECOGEN INC.的375.8倍（$2.0B vs $5.3M）。Ametek净利率更高（19.9% vs -75.1%，领先95.0%）。Ametek同比增速更快（13.4% vs -12.5%）。Ametek自由现金流更多（$527.3M vs $-2.6M）。过去两年Ametek的营收复合增速更高（7.3% vs -7.3%）
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
AME vs TGEN — 直观对比
营收规模更大
AME
是对方的375.8倍
$5.3M
营收增速更快
AME
高出25.9%
-12.5%
净利率更高
AME
高出95.0%
-75.1%
自由现金流更多
AME
多$529.9M
$-2.6M
两年增速更快
AME
近两年复合增速
-7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $5.3M |
| 净利润 | $398.6M | $-4.0M |
| 毛利率 | 36.0% | 36.8% |
| 营业利润率 | 25.3% | -77.8% |
| 净利率 | 19.9% | -75.1% |
| 营收同比 | 13.4% | -12.5% |
| 净利润同比 | 2.9% | -236.7% |
| 每股收益（稀释后） | $1.73 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMETGEN
| Q4 25 | $2.0B | $5.3M | ||
| Q3 25 | $1.9B | $7.2M | ||
| Q2 25 | $1.8B | $7.3M | ||
| Q1 25 | $1.7B | $7.3M | ||
| Q4 24 | $1.8B | $6.1M | ||
| Q3 24 | $1.7B | $5.6M | ||
| Q2 24 | $1.7B | $4.7M | ||
| Q1 24 | $1.7B | $6.2M |
净利润AMETGEN
| Q4 25 | $398.6M | $-4.0M | ||
| Q3 25 | $371.4M | $-2.1M | ||
| Q2 25 | $358.4M | $-1.5M | ||
| Q1 25 | $351.8M | $-659.9K | ||
| Q4 24 | $387.3M | $-1.2M | ||
| Q3 24 | $340.2M | $-930.4K | ||
| Q2 24 | $337.7M | $-1.5M | ||
| Q1 24 | $310.9M | $-1.1M |
毛利率AMETGEN
| Q4 25 | 36.0% | 36.8% | ||
| Q3 25 | 36.3% | 30.4% | ||
| Q2 25 | 35.8% | 33.8% | ||
| Q1 25 | 36.1% | 44.3% | ||
| Q4 24 | 36.6% | 45.0% | ||
| Q3 24 | 36.0% | 44.1% | ||
| Q2 24 | 36.0% | 44.0% | ||
| Q1 24 | 34.1% | 41.6% |
营业利润率AMETGEN
| Q4 25 | 25.3% | -77.8% | ||
| Q3 25 | 25.8% | -29.2% | ||
| Q2 25 | 26.0% | -19.4% | ||
| Q1 25 | 26.3% | -8.2% | ||
| Q4 24 | 26.6% | -18.7% | ||
| Q3 24 | 26.1% | -15.5% | ||
| Q2 24 | 25.8% | -31.2% | ||
| Q1 24 | 24.0% | -17.0% |
净利率AMETGEN
| Q4 25 | 19.9% | -75.1% | ||
| Q3 25 | 19.6% | -29.7% | ||
| Q2 25 | 20.2% | -20.1% | ||
| Q1 25 | 20.3% | -9.1% | ||
| Q4 24 | 22.0% | -19.5% | ||
| Q3 24 | 19.9% | -16.5% | ||
| Q2 24 | 19.5% | -32.5% | ||
| Q1 24 | 17.9% | -17.9% |
每股收益（稀释后）AMETGEN
| Q4 25 | $1.73 | $-0.14 | ||
| Q3 25 | $1.60 | $-0.07 | ||
| Q2 25 | $1.55 | $-0.06 | ||
| Q1 25 | $1.52 | $-0.03 | ||
| Q4 24 | $1.67 | $-0.05 | ||
| Q3 24 | $1.47 | $-0.04 | ||
| Q2 24 | $1.45 | $-0.06 | ||
| Q1 24 | $1.34 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.0M | $12.4M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $10.6B | $21.6M |
| 总资产 | $16.1B | $37.0M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资AMETGEN
| Q4 25 | $458.0M | $12.4M | ||
| Q3 25 | $439.2M | $15.3M | ||
| Q2 25 | $619.7M | $1.6M | ||
| Q1 25 | $399.0M | $4.1M | ||
| Q4 24 | $374.0M | $5.4M | ||
| Q3 24 | $396.3M | $1.3M | ||
| Q2 24 | $396.6M | $841.9K | ||
| Q1 24 | $373.8M | $1.5M |
总债务AMETGEN
| Q4 25 | $2.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMETGEN
| Q4 25 | $10.6B | $21.6M | ||
| Q3 25 | $10.5B | $25.5M | ||
| Q2 25 | $10.4B | $9.1M | ||
| Q1 25 | $10.0B | $9.6M | ||
| Q4 24 | $9.7B | $10.2M | ||
| Q3 24 | $9.6B | $11.3M | ||
| Q2 24 | $9.3B | $12.2M | ||
| Q1 24 | $9.0B | $13.7M |
总资产AMETGEN
| Q4 25 | $16.1B | $37.0M | ||
| Q3 25 | $16.2B | $41.5M | ||
| Q2 25 | $15.3B | $28.4M | ||
| Q1 25 | $14.9B | $29.7M | ||
| Q4 24 | $14.6B | $31.1M | ||
| Q3 24 | $14.8B | $27.5M | ||
| Q2 24 | $14.8B | $27.2M | ||
| Q1 24 | $14.9B | $28.5M |
负债/权益比AMETGEN
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $584.3M | $-2.6M |
| 自由现金流经营现金流 - 资本支出 | $527.3M | $-2.6M |
| 自由现金流率自由现金流/营收 | 26.4% | -49.3% |
| 资本支出强度资本支出/营收 | 2.9% | 0.9% |
| 现金转化率经营现金流/净利润 | 1.47× | — |
| 过去12个月自由现金流最近4个季度 | $1.7B | $-10.3M |
8季度趋势，按日历期对齐
经营现金流AMETGEN
| Q4 25 | $584.3M | $-2.6M | ||
| Q3 25 | $440.9M | $-3.6M | ||
| Q2 25 | $359.1M | $-2.6M | ||
| Q1 25 | $417.5M | $-1.2M | ||
| Q4 24 | $550.0M | $4.2M | ||
| Q3 24 | $487.2M | $-207.3K | ||
| Q2 24 | $381.4M | $-157.9K | ||
| Q1 24 | $410.2M | $248.2K |
自由现金流AMETGEN
| Q4 25 | $527.3M | $-2.6M | ||
| Q3 25 | $420.0M | $-3.6M | ||
| Q2 25 | $329.8M | $-2.7M | ||
| Q1 25 | $394.5M | $-1.3M | ||
| Q4 24 | $498.3M | $4.0M | ||
| Q3 24 | $460.9M | $-489.6K | ||
| Q2 24 | $360.0M | $-609.6K | ||
| Q1 24 | $382.6M | $143.3K |
自由现金流率AMETGEN
| Q4 25 | 26.4% | -49.3% | ||
| Q3 25 | 22.2% | -50.6% | ||
| Q2 25 | 18.5% | -37.7% | ||
| Q1 25 | 22.8% | -17.9% | ||
| Q4 24 | 28.3% | 66.6% | ||
| Q3 24 | 27.0% | -8.7% | ||
| Q2 24 | 20.8% | -12.9% | ||
| Q1 24 | 22.0% | 2.3% |
资本支出强度AMETGEN
| Q4 25 | 2.9% | 0.9% | ||
| Q3 25 | 1.1% | 1.0% | ||
| Q2 25 | 1.6% | 2.0% | ||
| Q1 25 | 1.3% | 1.8% | ||
| Q4 24 | 2.9% | 2.1% | ||
| Q3 24 | 1.5% | 5.0% | ||
| Q2 24 | 1.2% | 9.6% | ||
| Q1 24 | 1.6% | 1.7% |
现金转化率AMETGEN
| Q4 25 | 1.47× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 1.42× | — | ||
| Q3 24 | 1.43× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
TGEN
| Installation Services | $4.5M | 84% |
| Products Segment | $460.5K | 9% |
| Other | $394.7K | 7% |
